Facultative parasites can live freely in the outside world and can also invade the host to live parasitically under certain circumstances. For example, Strongyloides stercoralis generally lives freely mainly in the soil, but can also invade humans and live parasitically in the intestine. This type of parasite seriously affects the health of humans, livestock, and other hosts, and more and more research is focused on this type of parasite, such as exploring its life history, transmission routes, and prevalence to provide a reference for establishing diagnostic methods; selecting specific drugs for deworming tests and establishing control measures.
Ace Therapeutics is a specialist in the field of parasites, providing multi-omics services for facultative parasites, including genomics, epigenomics, transcriptomics, metabolomics, and microbiomics. Which aims to analyze at the molecular level the molecular mechanisms of the biological processes of facultative parasites. Every step from sample extraction, and library sequencing, to data analysis, has been scientifically and meticulously designed to guarantee high-quality research results.
1. Genomics
We provide genome sequencing services for facultative parasites, including next-generation library building and sequencing and third-generation library building and sequencing, based on an automated library building platform, automated quality control process, and high-performance computing platform. It is mainly used to study the whole genome assembly and annotation of certain facultative parasites, as well as evolutionary analysis and individual genomic variation detection. On this basis, we help you to explore biological questions related to evolution and pathogenesis.
2. Transcriptomics
We provide transcriptome services for facultative parasites, such as mRNA-seq, lncRNA-seq, circRNA-seq, small RNA-seq, single-cell transcriptomics sequencing, and spatial transcriptomics sequencing, which can help you explore the molecular mechanisms of evolution and pathogenesis of facultative parasites, as well as differences in transcriptional regulation between autotrophic and parasitic life, or the development of potent drugs.
3. Epigenomics
We provide epigenomics services for facultative parasites, including whole genome methylation sequencing (WGBS), ChlP-seq, RIP-seq, ATAC-seq, MeRlP-seq, RRBS, and single-cell ATAC-seq. Mainly analyze changes in gene expression levels based on non-genetic sequence alterations, such as DNA methylation and chromatin conformational changes. To investigate the molecular mechanism of a facultative parasite in biological processes such as cell differentiation, reproduction, and disease development.
Ace Therapeutics is a contract service provider focused on parasitology research, providing innovative solutions and technologies for parasite detection, genetic engineering, and drug development. We support global research institutes, universities, and pharmaceutical companies in advancing their research goals.